These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 18445082

  • 1. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J, Feliú A, Subiza JL, Uhlig J, Fernández-Caldas E.
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [Abstract] [Full Text] [Related]

  • 2. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P, Petrás M, Sýkora T, Lesná I.
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D.
    Vaccine; 2007 Jan 15; 25(5):957-64. PubMed ID: 17045368
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
    Bertoni M, Cosmi F, Bianchi I, Di Berardino L.
    Ann Allergy Asthma Immunol; 1999 Jan 15; 82(1):47-51. PubMed ID: 9988206
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.
    Alvarez-Cuesta E, Aragoneses-Gilsanz E, Martín-Garcia C, Berges-Gimeno P, Gonzalez-Mancebo E, Cuesta-Herranz J.
    Clin Exp Allergy; 2005 May 15; 35(5):572-8. PubMed ID: 15898977
    [Abstract] [Full Text] [Related]

  • 7. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L, Mewes T, Wolf H, Hansen I, Schnitker J, Mann WJ.
    Otolaryngol Head Neck Surg; 2005 Oct 15; 133(4):538-43. PubMed ID: 16213926
    [Abstract] [Full Text] [Related]

  • 8. Immunotherapy with alginate-conjugated two grass pollen extract in patients with allergic rhinoconjunctivitis.
    Tari MG, Mancino M, Pozzuoli G, Mauro B, Verga A, Monti G.
    Allergol Immunopathol (Madr); 1990 Oct 15; 18(1):35-40. PubMed ID: 2382596
    [Abstract] [Full Text] [Related]

  • 9. Nasal immunotherapy in weed-induced allergic rhinitis.
    Gaglani B, Borish L, Bartelson BL, Buchmeier A, Keller L, Nelson HS.
    Ann Allergy Asthma Immunol; 1997 Sep 15; 79(3):259-65. PubMed ID: 9305235
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F, Daza JC, Almeda E.
    J Investig Allergol Clin Immunol; 2003 Sep 15; 13(2):108-17. PubMed ID: 12968395
    [Abstract] [Full Text] [Related]

  • 11. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr 15; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 12. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
    Senna GE, Andri G, Dama AR, Falagiani P, Andri L.
    Allergol Immunopathol (Madr); 2000 Apr 15; 28(4):238-42. PubMed ID: 11022271
    [Abstract] [Full Text] [Related]

  • 13. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G, Hurley C, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2006 Feb 15; 117(2):263-8. PubMed ID: 16461125
    [Abstract] [Full Text] [Related]

  • 14. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
    Amar SM, Harbeck RJ, Sills M, Silveira LJ, O'Brien H, Nelson HS.
    J Allergy Clin Immunol; 2009 Jul 15; 124(1):150-156.e1-5. PubMed ID: 19523672
    [Abstract] [Full Text] [Related]

  • 15. Preventive symptomatic immunotherapy versus placebo in seasonal rhinitis due to grasses in children and to Parietaria in adult patients.
    Troise C, Bignardi D, Modena P, Pissacroia C, Di Berardino F.
    Allerg Immunol (Paris); 2000 Jun 15; 32(6):246-9. PubMed ID: 10971859
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C, Monzón S, Venturini M, Lezaun A.
    J Allergy Clin Immunol; 2006 Apr 15; 117(4):810-6. PubMed ID: 16630938
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of visual analog scales for the assessment of symptom severity in allergic rhinoconjunctivitis.
    Senti G, Vavricka BM, Graf N, Johansen P, Wüthrich B, Kündig TM.
    Ann Allergy Asthma Immunol; 2007 Feb 15; 98(2):134-8. PubMed ID: 17304879
    [Abstract] [Full Text] [Related]

  • 18. The type of sensitizing allergen can affect the evolution of respiratory allergy.
    Marogna M, Massolo A, Berra D, Zanon P, Chiodini E, Canonica GW, Passalacqua G.
    Allergy; 2006 Oct 15; 61(10):1209-15. PubMed ID: 16942571
    [Abstract] [Full Text] [Related]

  • 19. Nasal provocative test in patients allergic to pollen.
    Wojdas A, Rapiejko P, Zielnik-Jurkiewicz B, Kantor I.
    Ann Agric Environ Med; 2005 Oct 15; 12(2):173-6. PubMed ID: 16457469
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R, Panzani RC, Mistrello G.
    Eur Ann Allergy Clin Immunol; 2005 Mar 15; 37(3):103-8. PubMed ID: 15918297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.